14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

Trading levels for CRNX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 48.81 3.40 %
R2 48.33 2.40 %
R1 48.04 1.78 %
Current price: 47.20
Support S1 47.09 -0.227 %
S2 46.80 -0.85 %
S3 46.33 -1.85 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 48.03 1.76 %
R2 47.62 0.89 %
R1 47.53 0.699 %
Current price 47.20
Support S1 45.18 -4.28%
S2 42.76 -9.41%
S3 37.82 -19.87%

CRNX Predictions History

4 years ago
Michael Tyler predicted that CRNX for 2020-01-08 is going

4 years ago
JS predicted that CRNX for 2020-01-03 is going $25.69 (0.55%)

4 years ago
PHILLIPWELLS132027 predicted that CRNX for 2020-01-03 is going

Rank:

4 years ago
Michael Tyler predicted that CRNX for 2020-01-02 is going $25.82 (2.91%)

4 years ago
ReginaMIlls132085 predicted that CRNX for 2020-01-02 is going

Rank:

4 years ago
PHILLIPWELLS132027 predicted that CRNX for 2020-01-02 is going

Rank:
Click to get the best stock tips daily for free!

About Crinetics Pharmaceuticals Inc

Crinetics Pharmaceuticals Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat c... CRNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT